N
PASG icon

Nuveen’s Passage Bio PASG Stock Holding History

Nuveen’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,072
Closed -$622K – 3428
2022
Q1 		$622K Sell
10,072
-2,630
-21% -$217K ﹤0.01% 2949
2021
Q4 		$1.61M Buy
12,702
+1,818
+17% +$297K ﹤0.01% 2670
2021
Q3 		$2.17M Sell
10,884
-402
-4% -$95.9K ﹤0.01% 2636
2021
Q2 		$2.99M Buy
11,286
+5,243
+87% +$1.62M ﹤0.01% 2521
2021
Q1 		$2.11M Buy
6,043
+1,400
+30% +$598K ﹤0.01% 2586
2020
Q4 		$2.37M Buy
4,643
+651
+16% +$261K ﹤0.01% 2421
2020
Q3 		$1.05M Sell
3,992
-373
-9% -$128K ﹤0.01% 2668
2020
Q2 		$2.39M Buy
+4,365
New +$1.96M ﹤0.01% 2259

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's PASG Position: Q2 2022 in Review

Nuveen sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 10,072 shares — an estimated $622K sold.

Nuveen first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $2.99M in Q2 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Nuveen reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 10,072 Passage Bio shares in Q2 2022, an estimated $622K.
  • Nuveen first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
  • Nuveen's Passage Bio position peaked at $2.99M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.